SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-154280
Filing Date
2020-05-28
Accepted
2020-05-28 16:16:40
Documents
13
Period of Report
2020-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935875d8k.htm   iXBRL 8-K 42982
2 EX-10.1 d935875dex101.htm EX-10.1 111646
  Complete submission text file 0001193125-20-154280.txt   305548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA itci-20200527.xsd EX-101.SCH 3112
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200527_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200527_pre.xml EX-101.PRE 10981
12 EXTRACTED XBRL INSTANCE DOCUMENT d935875d8k_htm.xml XML 3271
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 20921262
SIC: 2834 Pharmaceutical Preparations